Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Come on let's get this done.
View:
Post by wearethebest on Dec 30, 2024 11:39am

Come on let's get this done.

If I had anything to do with the FDA I would be calling the company and trying this right away. This is people's  lives  we are playing with here and I'm sure some people in the FDA have family  that could  use this right away to. All I say is get on your high horse  and get this approved.
Comment by Sosak1 on Dec 30, 2024 12:07pm
This man is starting as new FDA head man. Somebody who is good in corresponding should get his e-mail from hospital and tell him about our  theralase. Comone people, I am not good at this. I bet he dosen't even know about us. https://profiles.hopkinsmedicine.org/provider/martin-a-makary/2701414  
Comment by blackjack0 on Dec 30, 2024 12:35pm
I have watched many of dr Makary's interviews, he is a voice of reason and if he is now heading up the FDA that is definitely a step in the right direction 
Comment by Infinity on Dec 30, 2024 12:44pm
I believe the BTD for cancer is not a guarantee.  But cerainly a possibility.  I seem to have more faith on the cure for multiple viruses and Dr.  Coombs that will deliver the results that we all need to increase the SP.  which will eventualy lead to a PP at higher valuation.  My thinking is based on this quote.. "Kevin Coombs, Professor, Medical Microbiology ...more  
Comment by Longholder99 on Dec 30, 2024 1:33pm
Typical mix of good things possibly coming down the road (virus inroads) with negativity on short term steps forward (btd).  Obvious tactic to most but may fool the slow or easily led.  Nice try!
Comment by bmk211 on Dec 30, 2024 1:42pm
Was there news regarding BTD?
Comment by Infinity on Dec 30, 2024 1:54pm
Long holder,  i don't get your thinking.  I want TLT to suceed just like everyone else.  I have a substantial stake in TLT.  I just don't have the faith in the current management and would prefer a JV and will happily to vote in the next AGM if there is an opportunity to get a JV going with a major pharma.  Just simply to get out of this Mom and PoP culture.  ...more  
Comment by Longholder99 on Dec 30, 2024 2:06pm
I think all that stuff is probably already in play.  Casting doubt on BTD, making comparisons to companies like Theranos in your previous posts. Never a reasonable discussion on the way forward for this company or how management could do a better job.  Employing scare tactics without constructive comments which if intellectually put forward I would happily accept as an opinion worth ...more  
Comment by N0taP00p on Dec 30, 2024 2:54pm
Priceless. 24x7 hype is the mirror opposite of using scare tactics. Didn't you last say BTD is coming well before January?    Debate is what the rest of us try to do. The easier path is to hide behind the ignore button. Smugness is easier than constructive discussion, I suppose. 
Comment by Infinity on Dec 30, 2024 3:44pm
I am just in favour of a hostile take over.  I hope that happens soon.  I will happily go along with the outcome.  The current management has no talent or money to get this cure that they stumbled upon to the general public.
Comment by 2b7f6fab on Dec 30, 2024 5:10pm
I sympathize with your frustration that the needle hasn't moved as fast or at all . (over a decade now for me and many others).  However, I've read on this MB that it takes 12 years or more to bring a new drug to market, typically at huge expense compared to the money spent by Theralase Mgmt.  Looking at the financials Yahoo provides the accumulated deficit is only $66 cdn ...more  
Comment by Infinity on Dec 31, 2024 1:05am
I share your view as well to a large extent.  I have lost all faith in the current managemnt.  The couple draw a salary over half a million $ every year and has not done any thing to the share holder. I am all in favour of a hostile take over.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250